Cargando…

Impact of Hepatitis C Treatment as Prevention for People Who Inject Drugs is sensitive to contact network structure

Treatment as Prevention (TasP) using directly-acting antivirals has been advocated for Hepatitis C Virus (HCV) in people who inject drugs (PWID), but treatment is expensive and TasP’s effectiveness is uncertain. Previous modelling has assumed a homogeneously-mixed population or a static network lack...

Descripción completa

Detalles Bibliográficos
Autores principales:	Metzig, Cornelia, Surey, Julian, Francis, Marie, Conneely, Jim, Abubakar, Ibrahim, White, Peter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431870/ https://www.ncbi.nlm.nih.gov/pubmed/28500290 http://dx.doi.org/10.1038/s41598-017-01862-6

Ejemplares similares

Integrated Hepatitis C Care for People Who Inject Drugs (Heplink): Protocol for a Feasibility Study in Primary Care
por: McCombe, Geoff, et al.
Publicado: (2018)

Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study
por: Taylor, Josephine E. B., et al.
Publicado: (2019)

Hepatitis C Transmission and Treatment in Contact Networks of People Who Inject Drugs
por: Rolls, David A., et al.
Publicado: (2013)

From peer-based to peer-led: redefining the role of peers across the hepatitis C care pathway: HepCare Europe
por: Surey, Julian, et al.
Publicado: (2019)

Improving engagement with healthcare in hepatitis C: a randomised controlled trial of a peer support intervention
por: Stagg, Helen R., et al.
Publicado: (2019)

Using peer advocates to improve access to services among hard-to-reach populations with hepatitis C: a qualitative study of client and provider relationships
por: MacLellan, Jennifer, et al.
Publicado: (2017)

Assessing uncertainty in the burden of hepatitis C virus: Comparison of estimated disease burden and treatment costs in the UK
por: Gubay, F., et al.
Publicado: (2018)

Incidence of hepatitis C among people who inject drugs in Ireland
por: Carew, Anne Marie, et al.
Publicado: (2017)

Peer Support Workers in Health: A Qualitative Metasynthesis of Their Experiences
por: MacLellan, Jennifer, et al.
Publicado: (2015)

Modeling the Impacts of Prevention and Treatment Interventions on Hepatitis C Among People Who Inject Drugs in China
por: Fang, Kailu, et al.
Publicado: (2023)

Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs
por: Platt, Lucy, et al.
Publicado: (2017)

An Overview of HIV Prevention Interventions for People Who Inject Drugs in Tanzania
por: Ratliff, Eric A., et al.
Publicado: (2013)

Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973–2030
por: Meijerink, Hinta, et al.
Publicado: (2017)

A Maximum Entropy Method for the Prediction of Size Distributions
por: Metzig, Cornelia, et al.
Publicado: (2020)

Eradication of hepatitis C infection: The importance of targeting people who inject drugs
por: Hellard, Margaret, et al.
Publicado: (2014)

Urgent action to fight hepatitis C in people who inject drugs in Europe
por: Dillon, John F., et al.
Publicado: (2016)

Mitochondrial Genotoxicity of Hepatitis C Treatment among People Who Inject Drugs
por: Durand, Mélusine, et al.
Publicado: (2021)

Therapy of chronic hepatitis C in people who inject drugs: focus on adherence
por: Frankova, Sona, et al.
Publicado: (2021)

Hepatitis C virus risk among young people who inject drugs
por: Mateu-Gelabert, Pedro, et al.
Publicado: (2022)

Improving the quality of needle and syringe programmes: an overlooked strategy for preventing hepatitis C among people who inject drugs
por: Leicht, Astrid
Publicado: (2014)

Modelling the impact of HIV and hepatitis C virus prevention and treatment interventions among people who inject drugs in Kenya
por: Stone, Jack, et al.
Publicado: (2022)

Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention
por: Eckhardt, Benjamin, et al.
Publicado: (2017)

1050. Hepatitis C Infection amongst People who Inject Drugs (PWID): Injection Practices and Risk Factors
por: Sankar, Nityasri, et al.
Publicado: (2020)

Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence
por: Higgs, Peter, et al.
Publicado: (2011)

Hepatitis C serosorting among people who inject drugs in rural Puerto Rico
por: Duncan, Ian, et al.
Publicado: (2017)

Modeling Hepatitis C Elimination Among People Who Inject Drugs in New Hampshire
por: Blake, Andrew, et al.
Publicado: (2021)

Hepatitis C Virus Dynamic Transmission Models Among People Who Inject Drugs
por: Woyesa, Shiferaw Bekele, et al.
Publicado: (2023)

Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries
por: Petersen, Zaino, et al.
Publicado: (2013)

Assisted injection among people who inject drugs in Thailand
por: Lee, William K, et al.
Publicado: (2013)

Hepatitis C Virus Phylogenetic Clustering Is Associated with the Social-Injecting Network in a Cohort of People Who Inject Drugs
por: Sacks-Davis, Rachel, et al.
Publicado: (2012)

Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis
por: Davis, Stephen M., et al.
Publicado: (2017)

Reduction in Depressive Symptoms in People who Inject Drugs who Are Cured of Hepatitis C Virus Infection: The HERO Study
por: Pericot-Valverde, Irene, et al.
Publicado: (2023)

Hepatitis C bio-behavioural surveys in people who inject drugs—a systematic review of sensitivity to the theoretical assumptions of respondent driven sampling
por: Buchanan, Ryan, et al.
Publicado: (2017)

A cross‐sectional study comparing men who have sex with men and inject drugs and people who inject drugs who are men and have sex with men in San Francisco: Implications for HIV and hepatitis C virus prevention
por: Artenie, Adelina, et al.
Publicado: (2022)

Transmission Patterns of HIV and Hepatitis C Virus among Networks of People Who Inject Drugs
por: Pilon, Richard, et al.
Publicado: (2011)

HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar
por: Khatib, Ahmed, et al.
Publicado: (2017)

The hepatitis C cascade of care in people who inject drugs in Dar es Salaam, Tanzania
por: Mohamed, Zameer, et al.
Publicado: (2018)

Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore
por: Falade-Nwulia, Oluwaseun, et al.
Publicado: (2020)

Are there missed opportunities for vaccinating against hepatitis B among people who inject drugs in the UK?
por: Njoroge, J., et al.
Publicado: (2019)

Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugs
por: Montoya, Vincent, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iuhoh17872joh3kv7jvhd4siki